Hansen Albert 4
4 · QUESTCOR PHARMACEUTICALS INC · Filed Dec 15, 2005
Insider Transaction Report
Form 4
Hansen Albert
Director
Transactions
- Conversion
Common Stock
2005-12-14$0.94/sh+672,545$632,999→ 672,545 total(indirect: By Corporate Opportunities Fund (Institutional), L.P.) - Conversion
Common Stock
2005-12-14$0.94/sh+124,309$117,000→ 124,309 total(indirect: By Corporate Opportunities Fund, L.,P.) - Conversion
Series B Convertible Preferred Stock
2005-12-14$0.94/sh−633$596→ 1,898 total(indirect: By Corporate Opporunities Fund (Institutional), L.P.)Exercise: $0.94From: 2003-01-15Exp: 2006-01-01→ Common Stock (672,545 underlying) - Conversion
Series B Convertible Preferred Stock
2005-12-14$0.94/sh−117$110→ 352 total(indirect: By Corporate Opportunities Fund, L.P.)Exercise: $0.94From: 2003-01-15Exp: 2006-01-01→ Common Stock (124,309 underlying)
Footnotes (3)
- [F1]The shares are redeemable by the issuer commencing January 1, 2006. The holder has the right to require the issuer to redeem its shares upon the occurrence of certain events.
- [F2]These shares are owned directly by Corporate Opportunities Fund, L.P. Mr. Hansen is a manager of SMM Corporeate Management, LLC, the general partner of Corporate Opportunities Fund, L.P. and a limited partner of Corporate Opportunities Fund, L.P. He disclaims any beneficial ownership of such shares except to the extent of his pecuniary interest in therein.
- [F3]These shares are owned directly by Corporate Opportunities Fund (Institutional), L.P. Mr. Hansen is a manager of SMM Corporeate Management, LLC, the general partner of Corporate Opportunities Fund (Institutional), L.P. and a limited partner of Corporate Opportunities Fund (Institutional), L.P. He disclaims any beneficial ownership of such shares except to the extent of his pecuniary interest in therein.